Abstract: A display unit includes a layer with a plurality of sub-regions which are arranged adjacently to one another along an illuminated edge of the layer. A corresponding number of symbols are arranged in the sub-regions. The display unit additionally has a plurality of light sources. The said light sources are arranged adjacently to one another along the illuminated edge of the layer. Each light source is configured to emit light into the respective sub-region of the layer via the illuminated edge of the layer. The display unit additionally has a limiting element which is arranged between the illuminated edge of the layer and the light sources and which is configured to limit the light emitted from the light sources for each sub-region such that the symbol in the respective sub-region is illuminated in a selective manner by the light sources.

Abstract: The disclosure relates to a method and a billing platform capable of building a real time aggregation without actually generating an invoice. In one embodiment, the method comprises steps of upon occurrence of an event to be charged, calculating (S102) a charge for the event; retrieving (S103) categorization attributes of charge information of the event; generating (S104) an identifier from the categorization attributes; and if an aggregation entity with the identifier does not exist in the billing platform, creating (S106) a new aggregation entity with the charge and the identifier, and storing the new aggregation entity in the billing platform. By storing a real time charge aggregation of an event in the platform rather than the event itself, a real time or continuous view of the upcoming invoice may be provided without actually generating the invoice.

Abstract: The present invention relates to a method of executing an export process for an automated meta model driven export of entity parts from a source data base (10), wherein the meta model specifies an abstract model of the source data base (10) and comprises a description of an entity part and/or a reference relationship between entity parts being resolvable from a referencing entity part to a referenced entity part. The method comprising the steps identifying (S14) a set of entity parts being identifiable outside the source data base (10) by a public key, an internal key, or a mixture of a public key and an internal key as first level entity parts, supplementing (S16) the set of first level entity parts by a set of second level entity parts being referenced by the first level parts according to at least one reference relationship described in the meta model, and writing (S18) export data for the set of first level parts and the set of second level parts into an export file.

Abstract: The present invention relates to tetrahydroisoquinolinone derivatives, a pharmaceutical composition comprising the same and the use of these derivatives in the inhibition of the Hsp70 protein. The compounds are useful in the treatment or inhibition of cancer, autoimmune disease, rheumatoid arthritis, inflammatory bowel disease and psoriasis.

Abstract: The present invention relates to tetrahydroisoquinolinone derivatives, a pharmaceutical composition comprising the same and the use of these derivatives in the inhibition of the Hsp70 protein. The compounds are useful in the treatment or inhibition of cancer, autoimmune disease, rheumatoid arthritis, inflammatory bowel disease and psoriasis.

Abstract: Method and data access unit for storage of data records for creating a serialized charging record formatted for insertion into a charging database. The method includes traversing the hierarchical charging record and for each part node of said hierarchical charging record identifying an attribute of the part node and determining if said attribute is a key attribute or a search attribute and if affirmative storing an attribute value of said attribute in a field of the serialized charging record based on a charging database configuration definition. A part segment comprising the attribute value and a data value token is stored in a payload body field of the serialized charging record with a part node indicator representing the location of the part node in the hierarchical charging record based on a hierarchical charging record configuration definition. A method and data access unit for creating a hierarchical charging record is also disclosed.

Abstract: An engine block arrangement includes an engine block and an exhaust gas system. The exhaust gas system, viewed in the flow direction of an exhaust gas flow, includes an exhaust gas turbocharger, an oxidation catalytic converter, a feed device for a urea-water solution, a particle filter, and an SCR catalytic converter arranged one behind the other. The exhaust gas turbocharger, the oxidation catalytic converter, the feed device for the urea-water solution, the particle filter, and the SCR catalytic converter are situated together on the engine block along one side thereof, the side being oriented essentially perpendicularly with respect to an output side of the engine block.

Abstract: The present invention relates to a method of executing an export process for an automated meta model driven export of entity parts from a source data base (10), wherein the meta model specifies an abstract model of the source data base (10) and comprises a description of an entity part and/or a reference relationship between entity parts being resolvable from a referencing entity part to a referenced entity part. The method comprising the steps identifying (S14) a set of entity parts being identifiable outside the source data base (10) by a public key, an internal key, or a mixture of a public key and an internal key as first level entity parts, supplementing (S16) the set of first level entity parts by a set of second level entity parts being referenced by the first level parts according to at least one reference relationship described in the meta model, and writing (S18) export data for the set of first level parts and the set of second level parts into an export file.

Abstract: Method and data access unit for storage of data records for creating a serialized charging record formatted for insertion into a charging database. The method includes traversing the hierarchical charging record and for each part node of said hierarchical charging record identifying an attribute of the part node and determining if said attribute is a key attribute or a search attribute and if affirmative storing an attribute value of said attribute in a field of the serialized charging record based on a charging database configuration definition. A part segment comprising the attribute value and a data value token is stored in a payload body field of the serialized charging record with a part node indicator representing the location of the part node in the hierarchical charging record based on a hierarchical charging record configuration definition. A method and data access unit for creating a hierarchical charging record is also disclosed.

Abstract: An engine block arrangement includes an engine block and an exhaust gas system. The exhaust gas system, viewed in the flow direction of an exhaust gas flow, includes an exhaust gas turbocharger, an oxidation catalytic converter, a feed device for a urea-water solution, a particle filter, and an SCR catalytic converter arranged one behind the other. The exhaust gas turbocharger, the oxidation catalytic converter, the feed device for the urea-water solution, the particle filter, and the SCR catalytic converter are situated together on the engine block along one side thereof, the side being oriented essentially perpendicularly with respect to an output side of the engine block.

Abstract: The invention concerns an improved process for producing high performance polyolefin member. The process comprises the steps of preparing a solution comprising a polyolefin and a solvent, extruding or spinning the solution into an air gap to form a fluid member, cooling the fluid member to form a solvent-containing gel member, and removing at least partly the solvent from the gel member to form a solid member before, during and/or after drawing the member. Furthermore, the process involves the presence of an antifoaming agent comprising an aryl sulphonic acid or an alkyl naphtyl sulphonic acid. The invention further concerns the geltruded polyolefin member comprising aryl sulphonic acid or alkyl naphtyl sulphonic acid.

Abstract: The invention relates to a cut resistant fabric comprising polyethylene fibers wherein said fibers are at least partially coated with a polymeric sheath comprising a fluoropolymer. The invention relates further to articles and in particular to articles of apparel and rugged outerwear comprising the inventive fabric. Examples of such articles include but are not limited to gloves, aprons, chaps, pants, boots, gators, shirts, jackets, coats, socks, shoes, undergarments, vests, waders, hats, gauntlets, and the like. The invention also relates to the use of the inventive fabric in articles of apparel and rugged outerwear and in particular in the examples mentioned hereinabove. In particular, the invention relates to gloves comprising the fabric of the invention.

Abstract: The present invention relates to an anti-HPV-16 E7 antibody obtainable by (a) eliciting an in vivo humoral response against highly purified HPV-16 E7 protein or a fragment thereof in a non-human vertebrate; and (b) affinity-purifying antibodies as obtained in the eliciting-step (a). Furthermore, the invention provides for the use of the anti-HPV-1 E7 antibody/antibodies for the preparation of a diagnostic composition of the (immuno-)histological detection of expressed HPV-16 E7 in a biological sample. Additionally, the invention relates to specific diagnostic compositions as well as to methods producing the same. The invention also provides for kits comprising (an) anti-HPV-16 E7 antibody(ies) of the invention or a diagnostic composition and discloses in vitro methods for the detection of a sexually transmittable disease or cancer, in particular cervical cancer, breast cancer, prostate cancer, anogenital cancer/neoplasia, penile cancer or head and neck cancer by using the described antibodies.